Status:

COMPLETED

Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

Lead Sponsor:

CrystalGenomics, Inc.

Conditions:

Healthy

Eligibility:

All Genders

19-50 years

Phase:

PHASE1

Brief Summary

This is a randomized, open-label, multiple-dose, parallel, Phase 1 study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG100650" in healthy volunteers.

Detailed Description

This is a randomized, open label, multiple-dose, parallel study to compare PK and to evaluate Drug-Drug Interaction of CG100650 in healthy volunteers. Total of 39 health volunteers will be randomized...

Eligibility Criteria

Inclusion

  • Key
  • Male or female aged ≥ 19 years and ≤ 50 years
  • Without inborn or chronic disease and no symptoms in physical examination
  • BMI(Body Mass Index) result ≥ 18kg/m 2 and ≤ 30kg/m2
  • Adequate clinical laboratory test results as evidenced by Hematology, Hemostasis, Biochemistry, Urinalysis, Serology and so on
  • Subject who understand the objective, method of the study and the characteristics of investigational drug and expected adverse events and provide written informed consent prior to study participation
  • Negative pregnancy test(hCG) and agree to contraception during the trial
  • Key

Exclusion

  • History of hypersensitivity to investigational products
  • History of hypersensitivity or allergic reaction to sulfonamide.
  • Patients with a history of asthma, acute rhinitis, nonspecific polyps, angioedema, urticaria or allergic reactions to aspirin or other nonsteroidal anti- inflammatory analgesics (including COX-2 inhibitors)
  • Genetically galactose intolerance, lactose intolerance or Glucose-Galactose Malabsorption
  • Any other reasons or situations that the investigator decides the patient is not eligible to participate the clinical trial.

Key Trial Info

Start Date :

December 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 10 2019

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT03775629

Start Date

December 1 2018

End Date

April 10 2019

Last Update

May 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 03080